Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

IL-2 -330 T/G SNP and serum values-potential new tumor markers in neuroendocrine tumors of the gastrointestinal tract and pancreas (GEP-NETs).

Journal of molecular medicine (Berlin, Germany) - 1 Apr 2010

Berković Maja Cigrovski, Jokić Mladen, Marout Jasminka, Radosević Senka, Zjacić-Rotkvić Vanja, Kapitanović Sanja

Abstract excerpt

Cytokines participate in tumorigenesis of gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Single nucleotide polymorphisms (SNPs) in cytokine genes influence expression of proteins and are evaluated in cancer susceptibility. The aim of this study was to evaluate IL-2 -330 T/G SNP and susc...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Biomarkers, Tumor
Share to Cytokines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gastrointestinal Neoplasms

Share to Hydroxyindoleacetic Acid

Share to Interleukin-2

Share to Neuroendocrine Tumors

Share to Pancreatic Neoplasms

Source

Identifiers

PMID: 20049409
DOI: 10.1007/s00109-009-0581-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20049409-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

IL-2 -330 T/G SNP and serum values-potential new tumor markers in neuroendocrine tumors of the gastrointestinal tract and pancreas (GEP-NETs).PMID 20049409Read ↗

IL-6-174 C/G polymorphism in the gastroenteropancreatic neuroendocrine tumors (GEP-NETs).Semantic proximity Read ↗

Interleukin 1β gene single-nucleotide polymorphisms and susceptibility to pancreatic neuroendocrine tumors.Semantic proximity Read ↗

TNF-alpha promoter single nucleotide polymorphisms in gastroenteropancreatic neuroendocrine tumors.Semantic proximity Read ↗

Genetic polymorphisms of inflammatory response gene TNF-α and its influence on sporadic pancreatic neuroendocrine tumors predisposition risk.Semantic proximity Read ↗

Genetic polymorphisms of<i>interleukin 1β</i>gene and sporadic pancreatic neuroendocrine tumors susceptibilitySemantic proximity Read ↗

Association of -330 interleukin-2 gene polymorphism with oral cancer.Semantic proximity Read ↗

High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).Semantic proximity Read ↗

Promoter polymorphisms of IL2, IL4, and risk of gastric cancer in a high-risk Chinese population.Semantic proximity Read ↗

Association of the interleukin-2 polymorphisms with interleukin-2 serum levels and risk of nasopharyngeal carcinoma.Semantic proximity Read ↗

The association between -330T/G polymorphism of interleukin 2 gene and bladder cancer.Semantic proximity Read ↗

Genetic determined downregulation of both type 1 and type 2 cytokine pathways might be protective against pancreatic cancer.Semantic proximity Read ↗

Prediction of malignant potential in reflux disease: are cytokine polymorphisms important?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.